药物对比
Troglitazone vs Dulaglutide
Troglitazone与Dulaglutide：已撤市的噻唑烷二酮类与现代GLP-1激动剂Trulicity治疗2型糖尿病。比较安全性、作用机制，以及为什么一种更受青睐。
此页面暂无可用的对比维度。
临床背景
This comparison is triggered when evaluating historical PPAR-gamma agonists against current GLP-1 receptor agonists for type 2 diabetes treatment options.
结论
Dulaglutide is the preferred modern agent as Troglitazone is no longer available due to severe liver toxicity risks.
全部药物对比